About Comanche Biopharma
Develops an investigational siRNA medicine for preterm preeclampsia.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Concord, United States
Year Founded
2020
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
comanchebiopharma.com
Domain Registered Date
Jul 9, 2020
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Series-B+ announced
startupintros.com
- Capital Raise
Raised $75,000,000 · Series-B+
startupintros.com
- Milestone
X account created (@ComancheBio)
38 followers
- Milestone
Website domain registered
comanchebiopharma.com
- Milestone
Company founded
Concord, United States
Investors & Backers
Atlas Venture
F-Prime Capital
GV
Lilly Asia Ventures
Longview Ventures
NEA
Funding History
Series-B+
· Feb 26, 2025
Undisclosed startupintros.com
Series-B+
· Jan 1, 2024
$75,000,000 startupintros.com
Founders & Leadership
Allison August
Chief Medical Officer
Work email & phone locked
Unlock →
Mike Young
Founder
Work email & phone locked
Unlock →
Richard Colvin
Global Head of Research and Development
Work email & phone locked
Unlock →
Scott Johnson
Chief Executive Officer & Co-Founder
Work email & phone locked
Unlock →
Thomas Scott Johnson
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026